46 related articles for article (PubMed ID: 17059890)
1. Pharmacological targeting of β-catenin in normal karyotype acute myeloid leukemia blasts.
Griffiths EA; Golding MC; Srivastava P; Povinelli BJ; James SR; Ford LA; Wetzler M; Wang ES; Nemeth MJ
Haematologica; 2015 Feb; 100(2):e49-52. PubMed ID: 25381132
[No Abstract] [Full Text] [Related]
2. Iron-laden blasts in refractory acute myeloid leukemia.
Vossen C; Im R; Horna P
J Hematop; 2023 Sep; 16(3):187-188. PubMed ID: 38175403
[TBL] [Abstract][Full Text] [Related]
3. Leukemic phase of Richter transformation: A mimic of acute myeloid leukemia that responded to Ibrutinib monotherapy.
Liu H; Miao Y; Ferrajoli A; Tang G; McDonnell T; Medeiros LJ; Hu S
Am J Hematol; 2020 Oct; 95(10):1221-1223. PubMed ID: 32162729
[No Abstract] [Full Text] [Related]
4. A dual origin for blood vessels.
Iruela-Arispe ML
Nature; 2018 Oct; 562(7726):195-197. PubMed ID: 30291309
[TBL] [Abstract][Full Text] [Related]
5. Keratan sulfate, an electrosensory neurosentient bioresponsive cell instructive glycosaminoglycan.
Melrose J
Glycobiology; 2024 Apr; 34(3):. PubMed ID: 38376199
[TBL] [Abstract][Full Text] [Related]
6. Podocalyxin Expressed in Antigen Presenting Cells Promotes Interaction With T Cells and Alters Centrosome Translocation to the Contact Site.
Amo L; Díez-García J; Tamayo-Orbegozo E; Maruri N; Larrucea S
Front Immunol; 2022; 13():835527. PubMed ID: 35711462
[TBL] [Abstract][Full Text] [Related]
7. Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma.
Tamayo-Orbegozo E; Amo L; Díez-García J; Amutio E; Riñón M; Alonso M; Arana P; Maruri N; Larrucea S
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32046309
[TBL] [Abstract][Full Text] [Related]
8. Keratan sulfate, a complex glycosaminoglycan with unique functional capability.
Caterson B; Melrose J
Glycobiology; 2018 Apr; 28(4):182-206. PubMed ID: 29340594
[TBL] [Abstract][Full Text] [Related]
9. TIE-2 expressing monocytes in human cancers.
Turrini R; Pabois A; Xenarios I; Coukos G; Delaloye JF; Doucey MA
Oncoimmunology; 2017; 6(4):e1303585. PubMed ID: 28507810
[TBL] [Abstract][Full Text] [Related]
10. Novel roles for podocalyxin in regulating stress myelopoiesis, Rap1a, and neutrophil migration.
Li P; Karaczyn AA; McGlauflin R; Favreau-Lessard AJ; Jachimowicz E; Vary CP; Xu K; Wojchowski DM; Sathyanarayana P
Exp Hematol; 2017 Jun; 50():77-83.e6. PubMed ID: 28408238
[TBL] [Abstract][Full Text] [Related]
11. Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinoma.
Zhou Y; Zhang L; Pan H; Wang B; Yan F; Fang X; Munnee K; Tang Z
PLoS One; 2015; 10(4):e0123208. PubMed ID: 25915207
[TBL] [Abstract][Full Text] [Related]
12. Role of podocalyxin in astrocytoma: Clinicopathological and
Huang T; Jin X; He L; Zhang M; Wu J; Wang Y; Fang J
Oncol Lett; 2013 Nov; 6(5):1390-1396. PubMed ID: 24179530
[TBL] [Abstract][Full Text] [Related]
13. Podocalyxin regulates astrocytoma cell invasion and survival against temozolomide.
Wu H; Yang L; Liao D; Chen Y; Wang W; Fang J
Exp Ther Med; 2013 Apr; 5(4):1025-1029. PubMed ID: 23596468
[TBL] [Abstract][Full Text] [Related]
14. miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia.
Favreau AJ; Cross EL; Sathyanarayana P
Am J Hematol; 2012 Apr; 87(4):442-6. PubMed ID: 22374871
[TBL] [Abstract][Full Text] [Related]
15. Podocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7.
Hsu YH; Lin WL; Hou YT; Pu YS; Shun CT; Chen CL; Wu YY; Chen JY; Chen TH; Jou TS
Am J Pathol; 2010 Jun; 176(6):3050-61. PubMed ID: 20395446
[TBL] [Abstract][Full Text] [Related]
16. Contribution of bone microenvironment to leukemogenesis and leukemia progression.
Ayala F; Dewar R; Kieran M; Kalluri R
Leukemia; 2009 Dec; 23(12):2233-41. PubMed ID: 19727127
[TBL] [Abstract][Full Text] [Related]
17. Podocalyxin is expressed in normal and leukemic monocytes.
Riccioni R; Calzolari A; Biffoni M; Senese M; Riti V; Petrucci E; Pasquini L; Cedrone M; Lo-Coco F; Diverio D; Foà R; Peschle C; Testa U
Blood Cells Mol Dis; 2006; 37(3):218-25. PubMed ID: 17059890
[TBL] [Abstract][Full Text] [Related]
18. Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts.
Riccioni R; Diverio D; Mariani G; Buffolino S; Riti V; Saulle E; Petrucci E; Cedrone M; Lo-Coco F; Foà R; Peschle C; Testa U
Stem Cells; 2007 Aug; 25(8):1862-71. PubMed ID: 17446561
[TBL] [Abstract][Full Text] [Related]
19. Podocalyxin: a marker of blasts in acute leukemia.
Kelley TW; Huntsman D; McNagny KM; Roskelley CD; Hsi ED
Am J Clin Pathol; 2005 Jul; 124(1):134-42. PubMed ID: 15923169
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
